Ongoing battle over transgenic mice

Scientist

Volumn 18, Issue 14, 2004, Pages 46-47

  Jaffe, Sam ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BORTEZOMIB;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; CANCER MODEL; CANCER RESEARCH; CLINICAL TRIAL; DNA MODIFICATION; DRUG RESEARCH; DRUG SCREENING; EUKARYOTIC CELL; EXPERIMENTAL MODEL; GENETIC ANALYSIS; GERM CELL; HUMAN; KNOCKOUT MOUSE; LEUKEMIA; MARKETING; MEDICAL RESEARCH; MOUSE; MOUSE STRAIN; NONHUMAN; PATENT; SHORT SURVEY; SPECIES DIFFERENCE; TRANSGENIC MOUSE;

ANIMALIA; EUKARYOTA; MUS MUSCULUS;

EID: 4243057254     PISSN: 08903670     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (3)

1. H. Gu et al., "Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting," Science, 265:103-6, 1994.
2. P. Leder et al., "Transgenic non-human mammals," US patent 4,736,866, 1988.
3. S. Blaug et al., "Managing innovation: university-industry partnerships and the licensing of the Harvard mouse," Nat Biotechnol, 22:761-3, June 2004.